Finally, we previously suggested that rare variations present in the genome of RA cases in addition to HLA-DRB1 SE could modulate the effect of this latter, leading to RA cases with different clinical characteristics. This evidence concerns the gene HLA-DRB1 and rheumatoid arthritis.